MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, M.
Right arrow Articles by Fan, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, M.
Right arrow Articles by Fan, Z.

Vol. 60, Issue 5, 900-906, November 2001

Differential Roles of p21Waf1 and p27Kip1 in Modulating Chemosensitivity and Their Possible Application in Drug Discovery Studies

Mathias Schmidt,1 Yang Lu, John M. Parant, Guillermina Lozano, Gerald Bacher,2 Thomas Beckers,1 and Zhen Fan

Departments of Experimental Therapeutics (M.S., Y.L., Z.F.) and Molecular Genetics (J.M.P., G.L.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and ASTA Medica AG (G.B., T.B.), Frankfurt, Germany

In this study, the differential role of the cyclin-dependent kinase (CDK) inhibitors p21Waf1 and p27Kip1 in cell cycle regulation was proposed for use in screening natural or synthetic compounds for cell cycle-dependent (particularly M phase-dependent) antineoplastic activity. p21Waf1 or p27Kip1 was ectopically expressed with an ecdysone-inducible mammalian expression system in a human colon adenocarcinoma cell line. Induction of p21Waf1 or p27Kip1 expression inhibited the activities of CDK2 and completely arrested cells at G1 phase of the cell cycle by p27Kip1 and at G1 and G2 phases by p21Waf1. We examined the sensitivity of these cells to several antineoplastic agents known to be cell cycle-dependent or -independent. Substantially increased resistance to cell cycle-dependent antineoplastic agents was found in the cells when the expression of p21Waf1 or p27Kip1 was induced. In contrast, only a desensitization to cell cycle-independent antineoplastic agents was found in the cells arrested by p21Waf1 or p27Kip1. Because p21Waf1 induces an additional block at G2 phase that inhibits cell entry into M phase, we further examined the difference between p21Waf1- and p27Kip1-induced cells in their sensitivity to D-24851, a novel M phase-dependent compound. We found that induction of p21Waf1 after exposure of the cells to D-24851 conferred stronger resistance than did induction of p27Kip1. Taken together, our results suggest that the differential effect of p21Waf1 and p27Kip1 on cell cycle regulation may be advantageous for screening chemical libraries for novel antineoplastic candidates that are cell cycle-dependent, and M phase-dependent in particular.


1 Current address: Byk Gulden GmbH, Dept. RPR/P3 Oncology Research, Konstanz, Germany.

2 Current address: Axxima Pharmaceuticals AG, Martinsried, Germany.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
J. Fink, K. Sanders, A. Rippl, S. Finkernagel, T. L. Beckers, and M. Schmidt
Cell type dependent effects of Polo-like kinase 1 inhibition compared with targeted polo box interference in cancer cell lines
Mol. Cancer Ther., December 1, 2007; 6(12): 3189 - 3197.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
C.-J. Lih, W. Wei, and S. N. Cohen
Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes
Genes & Dev., August 1, 2006; 20(15): 2082 - 2095.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Takahashi, F. Yamasaki, T. Sudo, H. Itamochi, S. Adachi, M. Tamamori-Adachi, and N. T. Ueno
Cyclin A-associated kinase activity is needed for paclitaxel sensitivity
Mol. Cancer Ther., July 1, 2005; 4(7): 1039 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. A. Waldman
Markers of Cell Cycle-Mediated Drug Resistance And Prognosis Of Patients Receiving Preoperative Combined Modality Therapy For Rectal Cancer
Ann. Surg. Oncol., November 1, 2004; 11(11): 949 - 950.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics